跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ADVIL PLUS ACETAMINOPHEN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ADVIL PLUS ACETAMINOPHEN
Authorized
STANDARD
ADVIL PLUS ACETAMINOPHEN
haleon canada ulc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
fd481ae3bda1e5c2
Company
haleon canada ulc
Type
Standard
Approval Details
Approval Id
fd481ae3bda1e5c2
Drug Approval Canada Name
ADVIL PLUS ACETAMINOPHEN
Product Name
ADVIL PLUS ACETAMINOPHEN
Status
Marketed
Status Date
2024-06-19
Original Market Date
2022-05-16
Din
02519267
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
OTC
Ahfs
28:08.04.92
Atc Original
N02BE51 ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS
Atc Name
n 02 be 51
Aig Number
0261410002
Company Name
haleon canada ulc
Company Address
450-55 Standish Court, Mississauga, Ontario, Canada, L5R 4B2
Active Ingredients
IBUPROFEN
125 MG
ACETAMINOPHEN
250 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
fd481ae3bda1e5c2
Type
Standard
Back to Health Canada Approvals